2021 The importance of cytogenomic tools for the prognosis and treatment of hematolo-oncologic disease 20210528
OBJECTIVES: Upon completion of this activity, the participant should be able to:
1. Review common terminology used in Cancer Cytogenetics and will be familiarized with common terminology used in Cancer Cytogenetics
2. Identify abnormalities with prognostic significance
3. Recognize chromosomal abnormalities in hematological malignancies and cancer
4. Discuss the importance of Cytogenetics in medicine
FACULTY DISCLOSURE: Carlos A. Tirado, Ph.D., FACMGG does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
PLANNERS DISCLOSURES: Carlos A. Tirado, Ph.D., FACMGG and Michelle Montez do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Information
Attachment | Size |
---|---|
![]() | 2.29 MB |
![]() | 935.59 KB |
Available Credit
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance